Search Ontology:
ChEBI
avanafil
- Term ID
- CHEBI:66876
- Synonyms
-
- (S)-4-(3-Chloro-4-methoxybenzylamino)-2-(2-hydroxymethylpyrrolidin-1-yl)-N-pyrimidin-2-ylmethyl-5-pyrimidinecarboxamide
- 4-[(3-chloro-4-methoxybenzyl)amino]-2-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-N-(pyrimidin-2-ylmethyl)pyrimidine-5-carboxamide
- avanafil
- Stendra
- Definition
- A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 4-[(3-chloro-4-methoxybenzyl)amino]-2-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]pyrimidine-5-carboxylic acid with the amino group of pyrimidin-2-ylmethylamine. Used for treatment of erectile dysfunction.
- References
-
- cas:330784-47-9
- drugcentral:4305
- kegg.drug:D03217
- patent:EP1366760
- patent:US6403597
- pubmed:18197727
- pubmed:18491987
- pubmed:20637970
- pubmed:20939743
- pubmed:21745238
- pubmed:21905762
- pubmed:22087063
- pubmed:22248153
- pubmed:22384456
- pubmed:22448738
- pubmed:22704456
- pubmed:22759639
- pubmed:22788525
- reaxys:11746013
- wikipedia.en:Avanafil
- Ontology
- ChEBI ( EBI )
Phenotype
Phenotype resulting from avanafil
Phenotype where environments contain avanafil
Phenotype modified by environments containing avanafil
Phenotype affecting avanafil
Human Disease Model